Bio-Matrix Scientific's Senior Management Attends Meeting for the California Institute for...

SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG), Managing Director and Chief Operating Officer Brian Pockett recently attended the Independent Citizens' Oversight Committee (ICOC), which was established as part of the rollout process for Proposition 71 related grants in stem

The ICOC meeting was conducted via video conferencing at various locations throughout California. Mr. Pockett represented Bio-Matrix at the ICOC's San Diego location which was held at Scripps Clinic in La Jolla on May 1, 2005.

The purpose of the meeting was to develop protocols for issuing stem cell research grants and site selection for the headquarters of the California Institute for Regenerative Medicine which is the governing body for issuing Proposition 71 grants.

Subsequent to the May 1st meeting, the ICOC selected San Francisco for its permanent headquarters for the California Institute for Regenerative Medicine.

"Now that the location for the California Institute for Regenerative Medicine's headquarters has been selected, it is anticipated the grant committee will move forward quickly on developing the requirements for stem cell related research grants," noted Bio-Matrix' Managing Director Brian Pockett.

The Independent Citizens' Oversight Committee is responsible for the oversight and management of the California Institute for Regenerative Medicine, which was established in 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research opportunities.

More information will be available shortly on the Company's website: www.BMXGonline.com.

About Bio-Matrix Scientific Group Inc.:

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG) are StemCells Inc. (Nasdaq:STEM), Thermogenesis Corporation (Nasdaq:KOOL) and Regeneration Technologies Inc. (Nasdaq:RTIX).

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.